300026 Tianjin Chase Sun Pharmaceutical
- 3.45
- -0.03-0.86%
Tianjin Chase Sun Pharmaceutical News
Tianjin Chase Sun Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Hongri Pharmaceutical: An indicative announcement on changes in the equity of shareholders holding 5% or more of the shares
Hongri Pharmaceutical: Simplified Equity Change Report
Hongri Pharmaceutical: Announcement on the share change ratio of shareholders holding 5% or more of the shares of more than 1%
Red Sun Pharmaceutical: Announcement on shareholders\' shares holding 5% or more of the shares awaiting freezing
Hongri Pharmaceutical: Announcement on the expiration of the holdings reduction plan for shareholders holding 5% or more of the shares and the lack of implementation of holdings reduction
Hongri Pharmaceutical: Announcement on the expiration of the passive reduction period for shareholders holding 5% or more of the shares
Hongri Pharmaceutical: Announcement on shareholders holding 5% or more of shares reduced by a cumulative share ratio of more than 1%
Hongri Pharmaceutical: Announcement on the completion of transfer registration of some shares of the company held by shareholders holding 5% or more of the shares by judicial auctions
Hongri Pharmaceutical: Announcement on the Withdrawal of Some Company Shares Held by Shareholders Holding 5% or More from the Judicial Auction
Hongri Pharmaceutical: Reminder notice that some shares of the company held by shareholders holding 5% or more of the shares will be judicially auctioned off
Hongri Pharmaceutical: Reminder notice that some shares of the company held by shareholders holding 5% or more of the shares will be judicially auctioned off
Red Sun Pharmaceutical: Announcement on shareholders\' shares holding 5% or more of the shares awaiting freezing
Red Sun Pharmaceutical: Announcement on shareholders\' shares holding 5% or more of the shares awaiting freezing
Red Sun Pharmaceutical: Pre-disclosure announcement on shareholders holding 5% or more of the shares to reduce their shareholding
Red Sun Pharmaceutical: Pre-disclosure Notice Concerning Passively Reducing Shareholdings by Shareholders Holding 5% or More
Red Sun Pharmaceutical: Announcement on the controlling shareholder\'s participation in the transfer of shares in Rongtong Securities\'s lending business to reach 1%
Red Sun Pharmaceutical: Announcement on shareholders holding 5% or more of the shares to reduce their shareholding ratio to 1%
Red Sun Pharmaceutical: 2022 Annual Equity Distribution Implementation Notice
Red Sun Pharmaceutical: Announcement on the completion of the share reduction plan for shareholders holding 5% or more of the shares
Analysis
Price Target
No Data
